Heterogeneity of melanoma-associated antigens detected by sera from patients receiving adjuvant allogeneic tumor vaccine immunotherapy.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000912:Antibodies, Neoplasm / Q000096:biosynthesis; D015478:Antigens, Heterophile; D000951:Antigens, Neoplasm / Q000276:immunology*; D000961:Antilymphocyte Serum; D001500:BCG Vaccine / Q000627:therapeutic use*; D002460:Cell Line; D006801:Humans; D007167:Immunotherapy; D008545:Melanoma / Q000188:drug therapy / Q000276:immunology* / Q000628:therapy
D000276:Adjuvants, Immunologic; D000912:Antibodies, Neoplasm; D015478:Antigens, Heterophile; D000951:Antigens, Neoplasm; D000961:Antilymphocyte Serum; D001500:BCG Vaccine